Zhi Luo
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 4
-
- Lipoproteins and Cardiovascular Health 5
- Cholesterol and Lipid Metabolism 3
-
- Liver Disease Diagnosis and Treatment 3
- Adipokines, Inflammation, and Metabolic Diseases 3
-
- RNA modifications and cancer 3
-
- Genetic Associations and Epidemiology 2
-
- Drug Transport and Resistance Mechanisms 2
Zhi Luo
27 papers receiving 328 citations
Peers
Comparison fields: 5 of 67
- Clinical Biochemistry 24
- Cardiology and Cardiovascular Medicine 65
- Endocrinology, Diabetes and Metabolism 42
- Rheumatology 38
- Surgery 94
Countries citing papers authored by Zhi Luo
This map shows the geographic impact of Zhi Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhi Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhi Luo more than expected).
Fields of papers citing papers by Zhi Luo
This network shows the impact of papers produced by Zhi Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhi Luo. The network helps show where Zhi Luo may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Zhi Luo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2026 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 7 | |
| 4 | 2024 | 4 | |
| 5 | 2024 | 3 | |
| 6 | 2023 | 3 | |
| 7 | 2022 | 9 | |
| 8 | 2022 | 6 | |
| 9 | 2022 | 4 | |
| 10 | 2022 | 2 | |
| 11 | 2021 | 5 | |
| 12 | 2020 | 14 | |
| 13 | 2019 | 3 | |
| 14 | 2018 | 12 | |
| 15 | 2018 | 6 | |
| 16 | 2018 | 16 | |
| 17 | 2018 | 9 | |
| 18 | 2018 | 71 | |
| 19 | 2017 | 29 | |
| 20 | 2007 | 62 |
About Zhi Luo
Zhi Luo is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine and Clinical Biochemistry, having authored 28 papers that have together received 333 indexed citations. Recurring topics across this work include Lipoproteins and Cardiovascular Health (5 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (4 papers), Liver Disease Diagnosis and Treatment (3 papers), RNA modifications and cancer (3 papers), Cholesterol and Lipid Metabolism (3 papers), Adipokines, Inflammation, and Metabolic Diseases (3 papers), Genetic Associations and Epidemiology (2 papers) and Drug Transport and Resistance Mechanisms (2 papers). The work is most often cited by research in Clinical Biochemistry (24 citations), Cardiology and Cardiovascular Medicine (65 citations) and Endocrinology, Diabetes and Metabolism (42 citations). Zhi Luo has collaborated with scholars based in China, India and United Kingdom. Frequent co-authors include Yongyan Song, Muhammad Irfan, Yun Chen, Zhan Lü, Guoyan Wang, Xiheng Hu, Chenqi Lu, Qiuhong Chen, Wei Zeng and Yuanyuan Peng. Their work appears in journals such as Scientific Reports, American Journal of Epidemiology and Journal of Cellular Physiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.